Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06869252
PHASE1/PHASE2

Autologous Adipose Cells Therapy

Sponsor: CERM INC.

View on ClinicalTrials.gov

Summary

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Key Details

Gender

All

Age Range

21 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-08-01

Completion Date

2026-02-01

Last Updated

2025-05-31

Healthy Volunteers

No

Interventions

BIOLOGICAL

Autologous Adipose Cells Therapy

Participants will receive Autologous Adipose Cells therapy treatment, and the safety and efficacy of the treatment will be monitored by the primary investigator up to 25 weeks.

Locations (2)

The Centre for Cosmetic Surgery & Medicine, Newark

Lewes, Delaware, United States

The Centre for Cosmetic Surgery & Medicine

Newark, Delaware, United States